$ENTBF News
Last published 4y ago
- 4y agoATAICMPSCYBNENTBF+2Ketamine Ushering in New Era in the Pharmacology Therapies for Neurological DisordersPR NewswireFinancialNewsMedia.com News Commentary PALM BEACH, Fla., July 27, 2022 /PRNewswire/ -- For years, ketamine was known for its use as an anesthetic or as a recreational drug. Its ability to provide quick and safe sedation saved many lives during the Vie
- 4y agoCSE:ENBICYBNENTBFCybin Completes Acquisition of Phase 1 DMT Study from Entheon BiomedicalBusiness Wire-- Expected to accelerate clinical development pathway of CYB004 for the potential treatment of anxiety disorders by nine months -- Cybin Inc. (NEO:CYBN) (NYSE:CYBN) ("Cybin" or the "Company"), a biopharmaceutical company focused on progressing "Psyc
- 4y agoCSE:ENBICYBNENTBFCybin Acquires DMT Clinical Study from Entheon BiomedicalBusiness Wire-- Acquisition of largest Phase 1 DMT study conducted to date is expected to accelerate CYB004 program timeline by nine months -- -- Phase 1 study evaluating pharmacokinetics/pharmacodynamics of DMT currently underway and will inform clinical path fo